Balcar L, Bauer D, Pomej K, Meischl T, et al. Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients. PLoS One 2023;18:e0282680.
PMID: 37027398